Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Marginal immunogenicity of factor VIII.

Literature DB >> 29217699

Marginal immunogenicity of factor VIII.

Kathleen P Pratt¹.

Abstract

Mesh：

Substances：
Factor VIII

Year: 2017 PMID： 29217699 PMCID： PMC5721287 DOI： 10.1182/blood-2017-10-811109

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
References

× No keyword cloud information.

8 in total

1. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells.

Authors: Kalaya Attanavanich; John F Kearney
Journal: J Immunol Date: 2004-01-15 Impact factor: 5.422

Review 2. Structure and function of the spleen.

Authors: Reina E Mebius; Georg Kraal
Journal: Nat Rev Immunol Date: 2005-08 Impact factor: 53.106

Review 3. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

Authors: Steven W Pipe; Robert R Montgomery; Kathleen P Pratt; Peter J Lenting; David Lillicrap
Journal: Blood Date: 2016-09-01 Impact factor: 22.113

4. Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice.

Authors: Ai-Hong Zhang; Jonathan Skupsky; David W Scott
Journal: Blood Date: 2010-12-15 Impact factor: 22.113

5. Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A.

Authors: A Navarrete; S Dasgupta; S Delignat; G Caligiuri; O D Christophe; J Bayry; A Nicoletti; S V Kaveri; S Lacroix-Desmazes
Journal: J Thromb Haemost Date: 2009-08-11 Impact factor: 5.824

Marginal immunogenicity of factor VIII.

1. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells.

Review 2. Structure and function of the spleen.

Review 3. Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.

4. Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice.

5. Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A.

6. Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.

7. Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A.

8. Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo.